Domů › Nemalobuněčný plicní karcinom › Washington › Tacoma
Klinické studie Nemalobuněčný plicní karcinom v Tacoma, WA
20 studií pro Nemalobuněčný plicní karcinom hledá účastníky v lokalitách v Tacoma a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Probíhá náborFáze 3
- Northwest Medical Specialties - Tacoma, Tacoma
- Northwest Medical Specialties - Gig Harbor, Gig Harbor · Vzdálenost 8 mi
- Northwest Medical Specialties - Puyallup Medical Oncology, Puyallup · Vzdálenost 8 mi
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Probíhá náborFáze 1/2
- Northwest Medical Specialties Tacoma /ID# 270469, Tacoma
- Vista Oncology - East Olympia /ID# 275438, Olympia · Vzdálenost 26 mi
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Probíhá náborFáze 3
- American Oncology Network Vista Oncology Division-West office, Olympia · Vzdálenost 26 mi
- American Oncology Network Vista Oncology Division-East office, Olympia · Vzdálenost 26 mi
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Probíhá náborFáze 3
- Vista Oncology Inc PS, Olympia · Vzdálenost 26 mi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Probíhá náborFáze 3
- American Oncology Network Vista Oncology Division-West office, Olympia · Vzdálenost 26 mi
- American Oncology Network Vista Oncology Division-East office, Olympia · Vzdálenost 26 mi
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Probíhá náborFáze 2
- Vista Oncology, Olympia · Vzdálenost 26 mi
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Probíhá náborFáze 1/2
- Northwest Medical Specialties, Tacoma
Pan-tumor MRD Study
Probíhá náborObservační studie
- Northwest Medical Specialties (NWMS), Tacoma
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Probíhá náborFáze 3
- Local Institution - 0499, Lacey · Vzdálenost 23 mi
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Probíhá náborFáze 3
- Research Site, Tacoma
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Probíhá náborFáze 2
- Northwest Medical Specialties Tacoma /ID# 270534, Tacoma
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Probíhá náborFáze 3
- Research Site, Tacoma
- Research Site, Olympia · Vzdálenost 26 mi
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Probíhá náborFáze 2/3
- Vista Oncology - East Olympia /ID# 262303, Olympia · Vzdálenost 26 mi
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Probíhá náborFáze 3
- Research Site, Tacoma
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Probíhá náborFáze 1
- Northwest Medical Specialties, Tacoma
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Probíhá náborFáze 3
- Research Site, Tacoma
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Probíhá náborFáze 1
- Exigent Research, LLC, Tacoma
- Northwest Medical Specialities, PLLC, Tacoma
- Northwest Medical Specialities. PLLC, Gig Harbor · Vzdálenost 8 mi
- a dalších 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Probíhá náborFáze 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · Vzdálenost 8 mi
- MultiCare Regional Cancer Center, Puyallup · Vzdálenost 8 mi
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Probíhá náborFáze 2
- USA09-0, Puyallup · Vzdálenost 8 mi
BostonGene and Exigent Genomic INsight Study
Probíhá náborObservační studie
- Northwest Medical Specialities, Puyallup · Vzdálenost 8 mi
Studie Nemalobuněčný plicní karcinom v jiných městech
- Houston, TX145 studií
- New York City, NY120 studií
- Arlington, VA104 studií
- Nashville, TN97 studií
- Boston, MA90 studií
- Los Angeles, CA87 studií
- St. Louis, MO73 studií
- Chicago, IL61 studií
- Baltimore, MD60 studií
- San Antonio, TX59 studií
- Columbus, OH56 studií
- Washington, DC55 studií
Další studie v Tacoma
- Rakovina prsu18 studií
- Ulcerózní kolitida15 studií
- Mnohočetný myelom13 studií
- Rakovina prostaty11 studií
- Crohnova choroba11 studií
- Metastatický karcinom9 studií
- Kolorektální karcinom9 studií
- Melanom7 studií
- Rakovina vaječníků7 studií
- Rakovina (všechny typy)6 studií
- Rakovina slinivky břišní6 studií
- Obesity6 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.